Cytek Biosciences has recurring revenue growth, improving margins, and ample cash that should continue compounding shareholder value over time. See why CTKB is a Buy.
President Donald Trump fired all six design review panelists who oversee his planned White House ballroom and triumphal arch, citing differences with the president. The Commission on Fine Arts was ...
A 24-parameter spectral flow cytometry panel was developed to monitor immune receptor expression in MS patients, aiding personalized treatment approaches. The panel detects 12 treatment-associated ...
Flow cytometry is a cutting-edge technology used to analyze and sort cells based on their physical and chemical properties. It plays a vital role in clinical diagnostics, immunology, oncology, and ...
Cellares announced multiple strategic technology partners Sept. 17 to advance its Cell Q. NJBIZ has reported extensively on the cell therapy manufacturer, which operates a Smart Factory in Bridgewater ...
Indianapolis — Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of its new IR820 and IR870 infrared dye antibody ...
Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the launch of its new IR820 and IR870 infrared dye antibody conjugates. For the ...
Bio-Rad Laboratories Inc. has introduced a new range of StarBright Dyes, providing greater choice and flexibility for spectral flow cytometry in immunology research. The first dye in the series, ...
FlexGen’s latest software feature delivers real-time, single-line visibility into battery sites — enabling faster response to alarms, less downtime, and improved operational efficiency FlexGen Power ...
Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial Invivoscribe Inc., a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results